The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury

Frontiers in Physiology - Switzerland
doi 10.3389/fphys.2018.00180
Full Text
Abstract

Available in full text

Categories
Physiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Reduction of Bleomycin Induced Lung Fibrosis by Candesartan Cilexetil, an Angiotensin II Type 1 Receptor Antagonist

Thorax
PulmonaryRespiratory Medicine
2004English

The Angiotensin II Type 2 Receptor Agonist Compound 21 Is Protective in Experimental Diabetes-Associated Atherosclerosis

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis

PLoS ONE
Multidisciplinary
2016English

2-Methoxyestradiol Attenuates Bleomycin-Induced Pulmonary Hypertension and Fibrosis in Estrogen-Deficient Rats

Vascular Pharmacology
Molecular MedicinePhysiologyPharmacology
2009English

Bleomycin-Induced Lung Injury

Journal of Cancer Research
2013English

Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis

American Journal of Pathology
Forensic MedicinePathology
2006English

Aryl Hydrocarbon Receptor Signals Attenuate Lung Fibrosis in the Bleomycin-Induced Mouse Model for Pulmonary Fibrosis Through Increase of Regulatory T Cells

Arthritis Research & Therapy
2020English

IGF1R Deficiency Attenuates Acute Inflammatory Response in a Bleomycin-Induced Lung Injury Mouse Model

Scientific Reports
Multidisciplinary
2017English

Implantation of Fetal Rat Lung Fragments Into Bleomycin-Induced Pulmonary Fibrosis

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy